According to SEC filings for the period ending December 2025, Krystal Biotech, Inc. (NASDAQ:KRYS) is held by 317 institutional firms.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| FMR LLC | 31 Dec, 2025 | 4,349,628 | 8,181 | 0.19% | $1,072,357,209.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 3,937,817 | 103,689 | 2.70% | $970,829,404.00 |
| Avoro Capital Advisors LLC | 31 Dec, 2025 | 2,888,888 | 111,111 | 4.00% | $712,226,448.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 2,778,845 | -13,363 | -0.48% | $685,096,446.00 |
| STATE STREET CORP | 31 Dec, 2025 | 1,342,303 | -53,664 | -3.84% | $330,931,382.00 |
| Soleus Capital Management, L.P. | 31 Dec, 2025 | 941,059 | -77,772 | -7.63% | $232,008,686.00 |
| Capital World Investors | 31 Dec, 2025 | 809,500 | 260 | 0.03% | $199,574,130.00 |
| Redmile Group, LLC | 31 Dec, 2025 | 677,705 | 16,317 | 2.47% | $167,081,391.00 |
| Hood River Capital Management LLC | 31 Dec, 2025 | 613,302 | 6,356 | 1.05% | $151,203,475.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 611,878 | 634 | 0.10% | $150,878,011.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Dec, 2025 | 492,968 | -40,996 | -7.68% | $121,538,226.00 |
| Frazier Life Sciences Management, L.P. | 31 Dec, 2025 | 488,460 | -200,000 | -29.05% | $120,424,928.00 |
| Bellevue Group AG | 31 Dec, 2025 | 410,323 | 409,011 | 31,174.62% | $101,161,033.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 386,505 | -250,483 | -39.32% | $95,288,943.00 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 31 Dec, 2025 | 376,340 | 227,038 | 152.07% | $92,782,864.00 |
| GOLDMAN SACHS GROUP INC | 31 Dec, 2025 | 293,525 | -54,725 | -15.71% | $72,365,654.00 |
| NORGES BANK | 31 Dec, 2025 | 284,573 | 284,573 | 0.00% | $70,158,627.00 |
| NORTHERN TRUST CORP | 31 Dec, 2025 | 247,443 | -722 | -0.29% | $61,004,597.00 |
| FIRST TRUST ADVISORS LP | 31 Dec, 2025 | 245,276 | -3,116 | -1.25% | $60,470,345.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Dec, 2025 | 242,774 | -89 | -0.04% | $59,853,502.00 |